Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
02/21/2007 | EP1140962B1 Novel derivatives from the class of oleandomycin |
02/21/2007 | EP1135503B1 Drug targets in candida albicans |
02/21/2007 | EP0871485B1 COMPOSITIONS AND METHODS FOR CATALYZING HYDROLYSIS OF HIV gp120 |
02/21/2007 | CN1918172A 利福霉素类似物及其用途 Rifamycin analogs and their use |
02/21/2007 | CN1918171A Chemokine ccr5 receptor modulators |
02/21/2007 | CN1918146A Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication |
02/21/2007 | CN1917902A Use for interleukin-33 (il-33) and the il-33 receptor complex |
02/21/2007 | CN1917899A Use of alkaline phosphatase for the detoxification of lps |
02/21/2007 | CN1916021A Amido glycoside of sea pearl oyster, prepartion method, and usage |
02/21/2007 | CN1916013A Pharmaceutical compounds |
02/21/2007 | CN1916006A New process for the preparation of vinyl-pyrrolidinone cephalosporine derivatives |
02/21/2007 | CN1915997A New process for the preparation of vinyl-pyrrolidinone cephalosporine derivatives |
02/21/2007 | CN1915989A Resultant Ruisidilabo from generic delavird and resveratrol, and synthetic method |
02/21/2007 | CN1915426A Method for producing yelk antibody liquid in high immunity |
02/21/2007 | CN1915425A Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
02/21/2007 | CN1915424A Acellular pertussis vaccines and methods of preparation thereof |
02/21/2007 | CN1915419A Medication of pasting on umbilicus to treat common cold, and preparation method |
02/21/2007 | CN1915406A Specific prescription of Chinese traditional medicine in series of 'quiet down' for flu and SARS like disease |
02/21/2007 | CN1915401A Composition of Chinese traditional medicine for treating phthisis, and application |
02/21/2007 | CN1915374A Medication of medical broth for treating condyloma acuminatum in type of heat toxin, and preparation method |
02/21/2007 | CN1915373A External scattering medication for treating tinea of feet, and preparation method |
02/21/2007 | CN1915359A Medication of pasting on umbilicus to treat influenza, and preparation method |
02/21/2007 | CN1915357A Medication of medical broth for treating condyloma acuminatum in type of qi deficiency, and preparation method |
02/21/2007 | CN1915348A Medication of medical broth for treating congestion type condyloma acuminatum, and preparation method |
02/21/2007 | CN1915328A Medication of steeping foot for treating tinea of feet, and preparation method |
02/21/2007 | CN1915319A Composition of Chinese traditional medicine in use for treating female inflammation |
02/21/2007 | CN1915303A Drop pills of Chinese globeflower, and preparing technique |
02/21/2007 | CN1915284A Medication of steeping foot for treating damp-heat type tinea of feet, and preparation method |
02/21/2007 | CN1915253A Exterior coating medication for treating tinea of feet, and preparation method |
02/21/2007 | CN1915248A Liandan antiinflammation drop pills, and preparation technique |
02/21/2007 | CN1915243A Exterior coating medication for treating ulcer in the oral cavity, and preparation method |
02/21/2007 | CN1915238A Medicinal composition for improving effect of anti hepatic fibrosis |
02/21/2007 | CN1915229A Medicine for treating chickens and pigs infected by mixed mycoplasma and other bacteria |
02/21/2007 | CN1301263C Nucleotide sequence for anti HIV infection and preventing AIDS and use thereof |
02/21/2007 | CN1301256C Method for preparing inophyllolide C2 and application of preparing medication of anti SARS |
02/21/2007 | CN1301255C Inhibitors of alpha l beta 2 integrin mediated cell adhesion |
02/21/2007 | CN1301134C Novel immune effect compound |
02/21/2007 | CN1301131C Viral myocarditis gene vaccine, its preparation method and application |
02/21/2007 | CN1301119C External use traditional Chinese medicine for treating beriberi |
02/21/2007 | CN1301116C Traditional Chinese medicine for treating mumps and preparation method thereof |
02/21/2007 | CN1301114C Medicament for treating tuberculosis and its preparation technology |
02/21/2007 | CN1301112C Compound antimicrobial medicine containing N-acetophenetidin-D-chitosamine |
02/21/2007 | CN1301107C Drop pills prepared from andrographolide sulfonated compounds and preparation method thereof |
02/21/2007 | CN1301106C Sterilizing gel |
02/21/2007 | CN1301095C 'Yinchai' drop pills for treating cold, fever and cough and preparation method |
02/20/2007 | US7179924 Use of benzotriazole UV absorbers |
02/20/2007 | US7179922 Chemical compounds |
02/20/2007 | US7179918 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
02/20/2007 | US7179888 Antigenic, non-toxic mutants of Clostridium septicum alpha toxin and vaccines, antibodies, sera, and methods of treatment therewith |
02/20/2007 | US7179826 Antiproliferative agnets; antitumor agents; anticancer agents; cardiovascular disorders; central nervous system disorders; autoimmune diseases; antiinflammatory agents |
02/20/2007 | US7179823 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
02/20/2007 | US7179817 For therapy and prophylaxis of peripheral arterial disease such as arteriosclerosis obliterans, thromboangiitis obliterans, Buerger's disease or diabetic neuropathy, sepsis, angiitis, nephritis, pneumonia, stroke, myocardial infarction, edematous state, atherosclerosis, varicosity such as hemorrhoid |
02/20/2007 | US7179811 Such as N-[1-(2-amino-3-methylbutyl)-4-piperidinyl]-3-[(2-methoxyethoxy)(6-methyl-2-pyridinyl)methyl]-7-methyl-3H-imidazo[4,5-b]pyridin-2-amine; infant infections |
02/20/2007 | US7179810 Phthalazinone-piperidino-derivatives as PDE4 inhibitors |
02/20/2007 | US7179805 Microbiocides; bactericides |
02/20/2007 | US7179803 Method of modulating ion channel functional activity |
02/20/2007 | US7179801 Cephem compounds |
02/20/2007 | US7179794 Antibiotics; bactericides |
02/20/2007 | US7179786 Variants of the NK1 fragment of hepatocyte growth factor/scatter factor (HGF/SF) and their use |
02/20/2007 | US7179632 Process for the production of allicin |
02/20/2007 | US7179470 Hepatitis-C virus testing |
02/20/2007 | US7179465 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type 1 interferon |
02/20/2007 | US7179462 α (2) macroglobulin receptor as a heat shock protein receptor and uses thereof |
02/20/2007 | CA2422374C Purine derivatives |
02/20/2007 | CA2407429C Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof |
02/20/2007 | CA2371174C Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors |
02/20/2007 | CA2289979C Methods of modulating immune coagulation |
02/20/2007 | CA2284058C Diffusional implantable delivery system |
02/20/2007 | CA2270551C Washing disinfectant for hygienic and surgical hand disinfection |
02/20/2007 | CA2251086C Glycopeptide compounds |
02/20/2007 | CA2218499C Chemokine binding protein and methods of use therefor |
02/20/2007 | CA2193210C Method of inducing an immune response with a live venezuelan equine encephalitis virus expressing a heterologous immunogen |
02/15/2007 | WO2007018843A2 Methods and compositions for diagnosis and treatment of influenza |
02/15/2007 | WO2007018622A2 Vaginal treatment composition |
02/15/2007 | WO2007018463A2 Interaction of moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system |
02/15/2007 | WO2007018229A1 Treatment of adult t-cell leukemia |
02/15/2007 | WO2007018194A1 Method for producing cercosporamide |
02/15/2007 | WO2007018049A1 Antigen capable of inducing neutralizing antibody for high risk-type human papillomavirus |
02/15/2007 | WO2007017859A1 Intravenous immunoglobulin composition |
02/15/2007 | WO2007017114A1 New substituted azathymidine derivatives and their use in the treatment of bacterial infectious diseases |
02/15/2007 | WO2006103638A3 Topical pharmaceutical compositions of terbinafine and processes for their preparation |
02/15/2007 | WO2006094756A3 Varicella zoster virus vaccine |
02/15/2007 | WO2005110487A3 Camptothecin derivatives conjugated in position 20 with integrin antagonists |
02/15/2007 | US20070037996 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants |
02/15/2007 | US20070037995 A Substantially Cell Membrane Impermeable Compound And Use Thereof |
02/15/2007 | US20070037867 Antihepatitis c virus agent and anti-hiv agent |
02/15/2007 | US20070037864 Intermediates for the preparation of lipoxin A4 analogs |
02/15/2007 | US20070037856 Pyrrole-Type compounds, compositions and methods for treating cancer or viral disease |
02/15/2007 | US20070037851 Inhibits binding of CCR3 ligands such as eotaxins to their target cells; inhibits physiological effects of binding; therapeutic and prophylactic agents for asthma, rhinitis, dermatitis, urticaria, conjunctivitis, inflammatory bowel; tissue infiltration of eosinophils, basophils, activated T cells |
02/15/2007 | US20070037841 Inhibitors |
02/15/2007 | US20070037838 Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1h-pyrano[2,3d 6,5-d']dipyrimidyne and 10-aza-analogue thereof |
02/15/2007 | US20070037834 Bicyclic pyrimidine derivatives |
02/15/2007 | US20070037832 2-butylamino-8-hydroxy-9-(6-methyl-3-pyridylmethyl)adenine; interferon inducing activity; antiviral, antiallergic agent; immune response modulator; hepatitis B and C, asthma, atopic dermatitis |
02/15/2007 | US20070037803 Benzimidazole derivatives |
02/15/2007 | US20070037786 Cephem compounds |
02/15/2007 | US20070037774 Novel cytarabine monophosphate prodrugs |
02/15/2007 | US20070037773 Methods and compositions for treating flaviviruses and pestiviruses |
02/15/2007 | US20070037772 Pyrazolidinol compounds |
02/15/2007 | US20070037770 Oligonucleotide N3'-P5' thiophosphoramidates: their synthesis and use |
02/15/2007 | US20070037757 Erythromycin scaffolds substituted at the 4'' position: 4'-O-[3-[[2-[(3-carboxy-7-chloro-1-cyclopropyl-1,4-dihydro-4-oxo-6-quinolinyl) amino]ethyl]amino]propionyl]-11-O-(2-dimethylaminoethoxymethyl)-(9E)-methoximino erythromycin A |